Assure Holdings Corp

Assure Holdings Corp. is a provider of outsourced intraoperative neuromonitoring and remote neurology services. The company delivers a turnkey suite of clinical and operational services to support surgeons and medical facilities during invasive procedures that place the nervous system at risk including neurosurgery, spine, cardiovascular, orthopedic, and ear, nose, and throat surgeries. The firm employs trained technologists that provide a direct point of contact in the operating room. Its physicians employed through Assure subsidiaries simultaneously monitor the functional integrity of patients’ neural structures throughout the procedure, communicating in real-time with the surgeon and technologist. The company was founded by Preston Thomas Parsons on May 24, 2017 and is headquartered in Englewood, CO.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Assure Holdings Corp. is a provider of outsourced intraoperative neuromonitoring and remote neurology services. The company delivers a turnkey suite of clinical and operational services to support surgeons and medical facilities during invasive procedures that place the nervous system at risk including neurosurgery, spine, cardiovascular, orthopedic, and ear, nose, and throat surgeries. The firm employs trained technologists that provide a direct point of contact in the operating room. Its physicians employed through Assure subsidiaries simultaneously monitor the functional integrity of patients’ neural structures throughout the procedure, communicating in real-time with the surgeon and technologist. The company was founded by Preston Thomas Parsons in 2016 and is headquartered in Denver, CO.

DENVER, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, will hold a conference call on Monday, November 14, 2022, at 4:30 p.m. Eastern Time to discuss its financial results for the third quarter ended September 30, 2022.

Assure Holdings Sets Third Quarter 2022 Conference Call for Monday, November 14, 2022, at 4:30 p.m. ET

DENVER, Oct. 14, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, is pleased to announce that it has performed its first neuromonitoring case in the state of New Jersey.

Assure Holdings Performs First Neuromonitoring Case in New Jersey

DENVER, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, announced that management will participate in the following investor conferences in October 2022:

Assure to Attend Investor Conferences in October 2022

NEW YORK, NY / ACCESSWIRE / August 24, 2022 / Aegis Capital Corp. acted as Sole Bookrunner on a $6.2 Million Underwritten Public Offering for Assure Holdings Corp. (NASDAQ:IONM). About Assure Holdings Corp. Assure Holdings Corp., through its subsidiaries, provides technical and professional intraoperative neuromonitoring surgical support services primarily associated with spine and head surgeries.

Aegis Capital Corp. Acted as Sole Bookrunner on a $6.2 Million Underwritten Public Offering for Assure Holdings Corp. (NASDAQ:IONM)

DENVER, Aug. 24, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (NASDAQ: IONM) ("Assure Holdings" or the "Company"), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, announced the closing of an underwritten public offering with gross proceeds to the Company of approximately $6.2 million, before deducting underwriting discounts and other estimated expenses payable by the Company. The offering equates to 5,576,087 shares at a price to the public of $1.12 per share. The Company intends to use the net proceeds from this offering for general corporate purposes, including, but not limited to, repayment of indebtedness and increasing working capital expenditures.

Assure Holdings Corp. Closes $6.2 Million Underwritten Public Offering of Common Stock

DENVER, Aug. 23, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, announced the appointment of Robynn Sweet to the position of vice president, strategic accounts.

Assure Holdings Further Strengthens Business Development Team with Hiring of Robynn Sweet as Vice President, Strategic Accounts

DENVER, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (NASDAQ: IONM) ("Assure Holdings" or the "Company"), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, today announced the pricing of an underwritten public offering with gross proceeds to the Company expected to be approximately $6.2 million, before deducting underwriting discounts and other estimated expenses payable by the Company. The offering equates to 5,576,087 shares at a price to the public of $1.12 per share. The Company intends to use the net proceeds from this offering for general corporate purposes, including, but not limited to, repayment of indebtedness and increasing working capital expenditures.

Assure Holdings Corp. Prices $6.2 Million Underwritten Public Offering of Common Stock

DENVER, Aug. 19, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (NASDAQ: IONM) ("Assure Holdings" or the "Company"), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, today announced that it intends to offer its shares of common stock in a public offering. The Company intends to use the net proceeds from this offering for general corporate purposes, including, but not limited to, working capital and other business opportunities. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Assure Holdings Corp. Announces Proposed Underwritten Public Offering of Common Stock

Assure Holdings Corp. (NASDAQ:IONM ) Q2 2022 Earnings Conference Call August 15, 2022 4:30 PM ET Company Participants Scott Kozak - Director of Investor Relations John Farlinger - Executive Chairman & Chief Executive Officer John Price - Chief Financial Officer Conference Call Participants Jim Sidoti - Sidoti and Company Scott Henry - ROTH Capital Operator Good afternoon, and welcome to the Assure Holdings' Second Quarter 2022 Earnings Call. All participants will be in a listen-only mode [Operator Instructions].

Assure Holdings Corp. (IONM) CEO John Farlinger on Q2 2022 Results - Earnings Call Transcript

Assure Holdings Corp. (IONM) delivered earnings and revenue surprises of -60.87% and 72.70%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Assure Holdings Corp. (IONM) Reports Q2 Loss, Misses Revenue Estimates

DENVER, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, reported financial results for the second quarter ended June 30, 2022.

Assure Holdings Reports Second Quarter 2022 Financial Results

DENVER, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, announced that it is attending the Sidoti Micro-Cap Virtual Conference.

Assure to Present at the Sidoti Micro-Cap Virtual Conference

DENVER, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, will hold a conference call on Monday, August 15, 2022, at 4:30 p.m. Eastern Time to discuss its financial results for the second quarter ended June 30, 2022.

Assure Holdings Sets Second Quarter 2022 Conference Call for Monday, August 15, 2022, at 4:30 p.m. ET

Aileron Therapeutics

Intelligent Living Application Group Inc

What you need to know about trading penny stocks in August The post How to Trade Penny Stocks in August 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

How to Trade Penny Stocks in August 2022

DENVER, July 14, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, today announced its plan to continue streamlining operations that prioritizes reaching positive operating cash flow.

Assure Holdings Announces Changes to Continue Streamlining Operations on Path to Becoming Cash Flow Positive from Operations

DENVER, July 06, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services has retained Hayden IR, LLC to broaden Assure's awareness within the investor and financial community and support the Company's investor relations program.

Assure Holdings Announces Partnership with Hayden IR

DENVER, June 14, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, announced that it is scheduled to present at the in-person Gravitas Securities Los Angeles Summit on June 23, 2022.

Assure to Present at the Gravitas Securities Los Angeles Summit

DENVER, June 02, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, announced that it is scheduled to present at the LD Micro Invitational on June 8, 2022.

Assure to Present at the LD Micro Invitational

DENVER, June 02, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, today announced the execution of strategic actions to make the business leaner and more profitable. These actions include the streamlining of operations and salary deferments for the executive management team which will prioritize resources for growth, accelerate the Company's path to profitability and create stakeholder value. The steps Assure is taking will reduce its monthly operating costs by greater than $200,000 per month.

Assure Holdings Executes Strategy to Make Business Leaner and More Profitable

DENVER, May 17, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, announced that management will participate in the following investor conferences in May and June 2022:

Assure to Attend Investor Conferences in May and June 2022

Assure Holdings Corp. (NASDAQ:IONM ) Q1 2022 Earnings Conference Call May 16, 2022 4:30 PM ET Company Participants Scott Kozak - Director of Investor Relations John Farlinger - Executive Chairman and CEO John Price - CFO Paul Webster - VP of Strategy Conference Call Participants Jim Sidoti - Sidoti and Company Bill Sutherland - The Benchmark Company Operator Good day, and welcome to the Assure Holdings' First Quarter 2022 Earnings Conference Call [Operator Instructions]. Please also note this event is being recorded.

Assure Holdings Corp. (IONM) CEO John Farlinger on Q1 2022 Results - Earnings Call Transcript

Assure Holdings Corp. (IONM) delivered earnings and revenue surprises of -216.67% and 27.68%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Assure Holdings Corp. (IONM) Reports Q1 Loss, Misses Revenue Estimates

First Quarter 2022 Managed Case Volume Increased Approximately 83% to 5,100

Assure Holdings Reports First Quarter 2022 Financial Results

DENVER, May 06, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, will hold a conference call on Monday, May 16, 2022, at 4:30 p.m. Eastern Time to discuss its financial results for the first quarter ended March 31, 2022.

Assure Holdings Sets First Quarter 2022 Conference Call for Monday, May 16, 2022, at 4:30 p.m. ET

DENVER, April 26, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, announced the appointment of James Watt to the position of national technologist director. Mr. Watt reports to Assure's vice president of clinical operations, Stephanie Krouse.

News for Assure Holdings Corp Stock (IONM)